In‑House Manufacturing Reshapes Pharma: Structural Stakes for Small‑Scale Biotechs
In‑house manufacturing is redefining capital allocation and talent pipelines across pharma, giving small biotechs that internalize production an asymmetric advantage while marginalizing…










